2Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E,Dominguez-Munoz E. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004;19:617-629.
3Gisbert JP, Pajares JM. Esomeprazole-based therapy in Helicobacter pylori eradication:a meta-analysis. Dig Liver Dis 2004;36:253-259.
4Beck J. Efficacy of esomeprazole in patients with acid-peptic disorders. Gastroenterol Nurs 2004;27:44-49.
5Laine L. Is it time for quadruple therapy to be first line? Can J Gastroenterol 2003;17(Suppl B):33B-35B.
6Malfertheiner P, Peitz U, Treiber G. What constitutes failure for Helicobacter pylori eradication therapy? Can J Gastroenterol 2003;17(Suppl B):53B-57B.
7Bhatia V, Ahuja V, Das B, Bal C, Sharma MP. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. J Gastroenterol Hepatol 2004;19:619-625.
8Georgopoulos SD, Ladas SD, Karatapanis S, Mentis A, Spiliadi C, Artikis V, Raptis SA. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci 2000;45:63-67.
9Parente F, Cucino C, Bianchi Porro G. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig Liver Dis 2003;35:523-528.
10Franzin L, Pennazio M, Cabodi D, Paolo Rossini F, Gioannini P. Clarithromycin and amoxiciUin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol 2000;40:96-100.
